{
  "name": "Protekt Therapeutics",
  "description": "Based in Israel, this company specializes in developing oral inhibitors targeting the kinase PKR to treat neurodegenerative and neuroinflammatory diseases.",
  "categoryId": 12,
  "size": "xs",
  "logoFile": "logos/protekt_therapeutics-logo.webp",
  "websiteUrl": "https://www.protektx.com/",
  "careersUrl": null,
  "linkedinId": null,
  "linkedinNum": null,
  "crunchbaseId": null,
  "ivcId": "A1000000208279",
  "finderId": "protekt-therapeutics",
  "xId": null,
  "facebookId": "Protektx",
  "breezyId": null,
  "comeetId": null,
  "greenhouseId": null,
  "leverId": null,
  "addresses": [
    {
      "street": "בר כוכבא",
      "houseNumber": 16,
      "city": "בני ברק",
      "lat": 32.0941294,
      "lon": 34.8235176
    }
  ],
  "isMultinational": false,
  "isActive": true
}